查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1666173

全球儲存自體血輸血市場 - 2025 至 2033 年

Global Stored Autologous Blood Transfusion Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球儲存自體血輸血市場規模達到 1,498 億美元，預計到 2033 年將達到 1,823 億美元，2025-2033 年預測期內的複合年成長率為 2.5%。

儲存自體血輸血是指患者在預定的手術或醫療程序之前捐捐血液，然後將該血液儲存起來以備將來在手術期間或手術後使用的過程。自體輸血的主要特徵是捐贈者和受贈者是同一個人。這消除了與異體（捐贈者）輸血相關的風險，例如輸血反應、感染和免疫併發症。

患者在計劃手術前幾天或幾週捐血，通常是在醫院或臨床環境中，採集的血液經過處理後儲存在血庫中，在血庫中使用抗凝劑保存以維持其活力（如果需要），儲存的血液在手術或恢復期間取出並重新輸入患者體內，這通常用於控制手術過程中的失血，如果患者在手術後失血的結果恢復結果。儲存的自體血可以減輕對外部捐血者的依賴，特別是在預計會失血的手術中。

市場動態：

促進因素與約束因素

手術量和高風險手術的成長

手術量和高風險手術的成長極大地推動了儲存自體血輸血市場的成長，並有望在預測期內透過增加對安全高效的血液管理系統的需求來推動市場的發展。高風險手術通常會造成大量失血，而自體輸血被認為是比異體輸血更安全、更可靠的替代方案。

在經常大量失血的脊椎手術中，最好使用儲存的自體血，因為它可以消除輸血相關感染和免疫反應的風險，這些風險對於高風險患者來說可能危及生命。

例如，根據美國國立衛生研究院 (NIH) 的數據，全球估計每年進行近 3.13 億例手術，其中美國每年進行約 50 萬例腰椎手術。高達 80% 的脊椎手術患者會經歷術後不適，20% 的患者會經歷持續的術後疼痛。每年約有 90 萬名美國成年人和 3 萬名加拿大成年人接受脊椎手術。脊椎手術的增加可能會增加失血過多的風險，這進一步增加了對儲存自體血輸血裝置的需求，用於在手術前儲存血液並在手術中輸入患者的血液。

在某些手術中的適用性有限

預計在某些手術中的適用性有限將阻礙儲存自體血輸血市場的成長。雖然自體血輸注對許多高風險手術非常有益，但它並不適用於所有類型的手術或不切實際。多種因素導致其適用性有限，從而限制了市場的成長潛力。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 手術量和高風險手術的成長
    • 限制
      • 在某些手術中的適用性有限
    • 機會
  • 影響分析

第5章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 6 章：依產品類型

  • 血液採集設備
  • 輸血套件
  • 血液處理產品
  • 血液儲存設備

第 7 章：按應用

  • 骨科手術
  • 一般外科手術
  • 婦產科手術
  • 其他

第 8 章：按儲存期限

  • 短期儲存
  • 長期儲存

第 9 章：按技術

  • 手動採血
  • 自動採血

第 10 章：按最終用戶

  • 血庫
  • 醫院
  • 門診手術中心

第 11 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 12 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 13 章：公司簡介

  • Terumo Corporation
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 主要進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Haemonetics Corporation
  • Medtronic
  • JMS Co. Ltd.
  • Narang Medical Limited.
  • Becton, Dickinson and Company
  • Fresenius Kabi AG
  • Nipro
  • Macopharma
  • Cardinal Health
  • Similar data will be provided for each market player.

第 14 章：附錄

簡介目錄
Product Code: MD9190

The global stored autologous blood transfusion market reached US$ 149.8 billion in 2024 and is expected to reach US$ 182.3 billion by 2033, growing at a CAGR of 2.5% during the forecast period 2025-2033.

Stored autologous blood transfusion refers to the process in which a patient donates their blood before a scheduled surgery or medical procedure, and this blood is then stored for future use during or after the procedure if needed. The key characteristic of autologous transfusion is that the donor and the recipient are the same individual. This eliminates the risks associated with allogeneic (donor) blood transfusions, such as transfusion reactions, infections, and immune complications.

The patient donates blood several days or weeks before planned surgery, typically in a hospital or clinical setting, the collected blood is processed and stored in blood banks, where it is preserved using anticoagulants to maintain its viability if needed, the stored blood is retrieved and reinfused into the patient during surgery or recovery, this is typically used to manage blood loss during the procedure if the patient experiences excessive blood loss after surgery, the stored blood can be reinfused to replenish lost blood volumes and improve recovery outcomes. Stored autologous blood can alleviate reliance on external blood donors, particularly in surgeries where blood loss is anticipated.

Market Dynamics: Drivers & Restraints

Growth in Surgical Volume and High-Risk Procedures

The growth in surgical volume and high-risk procedures is significantly driving the growth of the stored autologous blood transfusion market and is expected to drive the market over the forecast period by increasing the demand for safe and efficient blood management systems. High-risk surgeries often involve significant blood loss and autologous blood transfusion is considered a safer and more reliable alternative to allogeneic blood transfusions.

In spinal surgeries where large blood losses are common, using stored autologous blood is preferred because it eliminates the risk of transfusion-related infections and immunological reactions, which can be life-threatening in high-risk patients.

For instance, according to the National Institute of Health (NIH), global estimates suggest that close to 313 million surgeries are performed annually with approximately 500,000 lumbar spine surgeries each year in the United States. Up to 80% of spine surgery patients experience post-surgery discomfort and 20% will experience persistent post-surgical pain. Approximately 900,000 American and 30,000 Canadian adults undergo spine surgery annually. These rising spinal surgeries may increase the risk of excessive blood loss, which further boosts the demand for stored autologous blood transfusion devices to store the blood before surgery and to transfuse the patient's blood for such surgery.

Limited Applicability in Certain Surgeries

Limited applicability in certain surgeries is expected to hamper the growth of the stored autologous blood transfusion market. While autologous blood transfusion is highly beneficial in many high-risk surgeries, it is not suitable or practical in all types of surgeries. Several factors contribute to its limited applicability, and this restricts the market's growth potential.

Segment Analysis

The global stored autologous blood transfusion market is segmented based on product type, application, storage duration, technology, end-user, and region.

Product Type:

Blood collection devices segment is expected to dominate the global stored autologous blood transfusion market share

Blood collection devices are medical tools used in healthcare settings like hospitals, diagnostic laboratories, and blood donation centers for safe and efficient collection, storage, and transportation of blood samples. These devices, including syringes, vacuum-based tubes, capillary systems, lancets, needles, and blood bags, ensure minimal discomfort for patients, prevent contamination, and maintain sample integrity for accurate diagnostic testing or transfusion purposes.

The blood collection devices segment is driving the global stored autologous blood transfusion market due to the significant product launches, demand for safe and efficient methods, technological advancements, and minimally invasive procedures. Moreover, the rise in surgeries requiring autologous blood transfusions and increased awareness about allogeneic blood transfusion risks have increased the need for advanced devices further fueling this segment's growth.

For instance, in March 2024, BD has launched the BD Vacutainer UltraTouch Push Button Blood Collection Set in India to reduce patient pain and discomfort during blood collection. The set uses BD RightGauge technology, a thinner needle, and BD PentaPoint Technology, resulting in a significant decrease in insertion pain. The BD Push Button Technology reduces needle injury chances by 88%. The set is designed to minimize the need for needles during blood collection.

Moreover, in October 2024, Ahlstrom launched Lipid Saver, a new solution for collecting, transporting, and storing fatty acids from whole blood samples. The innovative specimen collection card allows for easy, reliable, and long-term preservation of saturated and unsaturated fatty acids at room temperature.

Geographical Analysis

North America is expected to hold a significant position in the global stored autologous blood transfusion market share

North America dominates the global stored autologous blood transfusion market due to high surgical volumes. The increased awareness of transfusion-related risks, regulatory frameworks in the US, technological advancements in blood collection and storage devices, and leading market players contribute to North America's dominance.

Furthermore, the launch of new products and advancements in the region help the region to grow during the forecast period. For instance, in October 2024, Terumo Blood and Cell Technologies (Terumo BCT) has introduced the Reveos Automated Blood Processing System in the US, aiming to streamline the whole blood processing process and improve efficiency. The system will be used by Carter BloodCare in Texas to manufacture platelets, red blood cells, and plasma for transfusion.

Moreover, according to the Leukemia & Lymphoma Society, about every 3 minutes, a person in the US is diagnosed with either leukemia, lymphoma, or myeloma. In the year 2024, the overall projected case of leukemia, lymphoma, or myeloma in the US is 187,740. New incidences of leukemia, lymphoma and myeloma cases will represent 9.4% of the new cancer cases projected for diagnosis in the US in the year 2024 which will be 2,001,140 cases. Thus, the above factors contribute to the region's dominance in the global market.

Competitive Landscape

The major global players in the stored autologous blood transfusion market include Terumo Corporation, Haemonetics Corporation, Medtronic, JMS Co. Ltd., Narang Medical Limited., Becton, Dickinson and Company, Fresenius Kabi AG, Nipro, Macopharma and Cardinal Health among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Stored Autologous Blood Transfusion Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by Storage Duration
  • 3.4. Snippet by Technology
  • 3.5. Snippet by End User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growth in Surgical Volume and High-Risk Procedures
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Applicability in Certain Surgeries
    • 4.1.3. Opportunity
  • 4.2. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Blood Collection Devices*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Blood Transfusion Kits
  • 6.4. Blood Processing Products
  • 6.5. Blood Storage Devices

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Orthopedic Surgeries*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. General Surgeries
  • 7.4. Obstetrics & Gynecology Surgeries
  • 7.5. Others

8. By Storage Duration

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Storage Duration
    • 8.1.2. Market Attractiveness Index, By Storage Duration
  • 8.2. Short-Term Storage*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Long-Term Storage

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology
  • 9.2. Manual Blood Collection*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Automated Blood Collection

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Blood Banks*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Hospitals
  • 10.4. Ambulatory Surgical Centers

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Storage Duration
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. U.S.
      • 11.2.8.2. Canada
      • 11.2.8.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Storage Duration
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. U.K.
      • 11.3.8.3. France
      • 11.3.8.4. Spain
      • 11.3.8.5. Italy
      • 11.3.8.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Storage Duration
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Brazil
      • 11.4.8.2. Argentina
      • 11.4.8.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Storage Duration
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. South Korea
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Storage Duration
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

Key Market Players

  • 13.1. Terumo Corporation*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio
      • 13.1.2.1. Product Description
      • 13.1.2.2. Product Key Performance Indicators (KPIs)
      • 13.1.2.3. Historic and Forecasted Product Sales
      • 13.1.2.4. Product Sales Volume
    • 13.1.3. Financial Overview
      • 13.1.3.1. Company Revenue's
      • 13.1.3.2. Geographical Revenue Shares
      • 13.1.3.3. Revenue Forecasts
    • 13.1.4. Key Developments
      • 13.1.4.1. Mergers & Acquisitions
      • 13.1.4.2. Key Product Development Activities
      • 13.1.4.3. Regulatory Approvals etc.
    • 13.1.5. SWOT Analysis
  • 13.2. Haemonetics Corporation
  • 13.3. Medtronic
  • 13.4. JMS Co. Ltd.
  • 13.5. Narang Medical Limited.
  • 13.6. Becton, Dickinson and Company
  • 13.7. Fresenius Kabi AG
  • 13.8. Nipro
  • 13.9. Macopharma
  • 13.10. Cardinal Health
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us